Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults
Conor H. Murray, Ilaria Tare, Claire Perry, et al.
Psychopharmacology (2021) Vol. 239, Iss. 6, pp. 1735-1747
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Default Mode Network Modulation by Psychedelics: A Systematic Review
James J Gattuso, Daniel Perkins, Simon Ruffell, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 26, Iss. 3, pp. 155-188
Open Access | Times Cited: 105
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Federico Cavanna, Stephanie Müller, Laura Alethia de la Fuente, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
M. Ishrat Husain, Nicole Ledwos, Elise Fellows, et al.
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 30
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J. Murphy, Rachael L. Sumner, William J. Evans, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 6, pp. 511-521
Open Access | Times Cited: 28
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
Conor H. Murray, Joel Frohlich, Connor J. Haggarty, et al.
Neuropsychopharmacology (2024)
Closed Access | Times Cited: 12
Exploring mechanisms of psychedelic action using neuroimaging
David Erritzøe, Christopher Timmermann, Kate Godfrey, et al.
Nature Mental Health (2024) Vol. 2, Iss. 2, pp. 141-153
Closed Access | Times Cited: 11
Microdosing Psychedelics: Current Evidence From Controlled Studies
Robin J. Murphy, Suresh Muthukumaraswamy, Harriet de Wit
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 500-511
Open Access | Times Cited: 10
Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
Robin J. Murphy, Kate Godfrey, Alexander D. Shaw, et al.
BMC Neuroscience (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
James E. Glazer, Conor H. Murray, Robin Nusslock, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 2, pp. 418-426
Closed Access | Times Cited: 35
Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans
Flora Moujaes, Katrin H. Preller, Jie Lisa Ji, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 12, pp. 1061-1070
Open Access | Times Cited: 31
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications
Clément Dondé, Joshua T. Kantrowitz, Alice Medalia, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105098-105098
Open Access | Times Cited: 20
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
Michael Tagen, Daniel Mantuani, Liron van Heerden, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 9, pp. 876-890
Closed Access | Times Cited: 20
Cardiovascular safety of psychedelic medicine: current status and future directions
Agnieszka Wsół
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1362-1380
Open Access | Times Cited: 20
Clinical pharmacological innovation in the treatment of depression
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 349-362
Closed Access | Times Cited: 13
Synthetic surprise as the foundation of the psychedelic experience
Roberto De Filippo, Dietmar Schmitz
Neuroscience & Biobehavioral Reviews (2024) Vol. 157, pp. 105538-105538
Open Access | Times Cited: 4
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
Vince Polito, Paul Liknaitzky
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 701-711
Open Access | Times Cited: 4
Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights
I. Craig Henderson, Ronnie Elsaadany, Gabriel Chan, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access
Side Effects of Microdosing Lysergic Acid Diethylamide and Psilocybin: A Systematic Review of Potential Physiological and Psychiatric Outcomes
Stefan Modzelewski, Anna Stankiewicz, Napoleon Waszkiewicz, et al.
Neuropharmacology (2025), pp. 110402-110402
Closed Access
Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT)
Juan Piccinini, Yonatan Sanz Perl, Carla Pallavicini, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?
Iva Totomanova, Eline Haijen, Petra P.M. Hurks, et al.
International review of neurobiology (2025)
Closed Access
The Altered States Database: Psychometric data from a systematic literature review
Johanna Prugger, Ekin Derdiyok, Jannis Dinkelacker, et al.
Scientific Data (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Greater subjective effects of a low dose of LSD in participants with depressed mood
Hanna Molla, Royce Lee, Ilaria Tare, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 5, pp. 774-781
Closed Access | Times Cited: 10
The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics
Paweł Orłowski, Justyna Hobot, Anastasia Ruban, et al.
Journal of Psychopharmacology (2023) Vol. 38, Iss. 1, pp. 68-79
Closed Access | Times Cited: 8
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
Antonio Inserra, Alexandre Piot, Danilo De Gregorio, et al.
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 733-754
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top